Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sean Emery

Showing results (1-10 of 140) with videos related to

Pageof 14
Sort By:
Lancet (London, England)|August 4, 2009
Raltegravir: a new choice in HIV and new chances for researchSean Emery, Alan Winston
Expert Review of Clinical Pharmacology|November 25, 2011
Metabolic disorders and cardiovascular consequences of  HIV infection and antiretroviral  therapyAllison Martin, Sean Emery
The Medical Journal of Australia|February 14, 2002
HIV medicineSean Emery, David A Cooper
Clinical Science (London, England : 1979)|December 13, 2005
Therapeutic vaccination against HIV: current progress and future possibilitiesRebekah L Puls, Sean Emery
Current Opinion in HIV and AIDS|June 18, 2009
Predicting the potential benefits of early initiation of ART: time to do a trial to find outAndrew N Phillips, Sean Emery
Statistics in Medicine|December 18, 2002
Selective exclusion of treatment arms in multi-arm randomized clinical trialsMatthew G Law, Sean Emery
AIDS Reviews|October 7, 2011
Bone turnover markers in HIV diseaseHila Haskelberg, Andrew Carr, Sean Emery
Journal of HIV Therapy|March 12, 2010
Inflammation and gut permeabilityHelen Byakwaga, Christoph Boesecke, Sean Emery
AIDS Reviews|July 11, 2008
Restorative interventions for HIV facial lipoatrophyDianne Carey, Steven Liew, Sean Emery
Lancet (London, England)|July 21, 2009
Antiretroviral roll-out: the problem of second-line therapyMark Boyd, Sean Emery, David A Cooper
Pageof 14

Showing results (1-10 of 140) with videos related to

Sort By:
Pageof 14
Lancet (London, England)|August 4, 2009
Raltegravir: a new choice in HIV and new chances for researchSean Emery, Alan Winston
Expert Review of Clinical Pharmacology|November 25, 2011
Metabolic disorders and cardiovascular consequences of  HIV infection and antiretroviral  therapyAllison Martin, Sean Emery
The Medical Journal of Australia|February 14, 2002
HIV medicineSean Emery, David A Cooper
Clinical Science (London, England : 1979)|December 13, 2005
Therapeutic vaccination against HIV: current progress and future possibilitiesRebekah L Puls, Sean Emery
Current Opinion in HIV and AIDS|June 18, 2009
Predicting the potential benefits of early initiation of ART: time to do a trial to find outAndrew N Phillips, Sean Emery
Statistics in Medicine|December 18, 2002
Selective exclusion of treatment arms in multi-arm randomized clinical trialsMatthew G Law, Sean Emery
AIDS Reviews|October 7, 2011
Bone turnover markers in HIV diseaseHila Haskelberg, Andrew Carr, Sean Emery
Journal of HIV Therapy|March 12, 2010
Inflammation and gut permeabilityHelen Byakwaga, Christoph Boesecke, Sean Emery
AIDS Reviews|July 11, 2008
Restorative interventions for HIV facial lipoatrophyDianne Carey, Steven Liew, Sean Emery
Lancet (London, England)|July 21, 2009
Antiretroviral roll-out: the problem of second-line therapyMark Boyd, Sean Emery, David A Cooper
Pageof 14